Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Styling without sheddin: novel topical formula reduces hair shedding by contracting the arrector pili muscle (CROSBI ID 303851)

Prilog u časopisu | stručni rad | međunarodna recenzija

McCoy John ; Goren Andy ; Kovacevic Maja ; Situm Mirna ; Stanimirovic Andrija ; Shapiro Jerry ; Sinclair Rodney Styling without sheddin: novel topical formula reduces hair shedding by contracting the arrector pili muscle // Dermatologic therapy, 31 (2018), 1; 121-122. doi: 10.1111/dth.12575

Podaci o odgovornosti

McCoy John ; Goren Andy ; Kovacevic Maja ; Situm Mirna ; Stanimirovic Andrija ; Shapiro Jerry ; Sinclair Rodney

engleski

Styling without sheddin: novel topical formula reduces hair shedding by contracting the arrector pili muscle

Approximately 40% of women experience excessive hair shedding during styling (e.g., hair brushing). Previously, we demonstrated that topically applied phenylephrine, a potent α1 adrenergic receptor agonist, can be used to contract the arrector pili muscle of the follicular unit ; thus, increasing the force required to pluck hair and reducing shedding during brushing. While demonstrating efficacy, phenylephrine has several drawbacks when applied to the scalp, including the possibility cardiovascular events. We hypothesized that a high concentration of a weak α1 agonist would allow for: (a) rapid penetration through the stratum corneum eliciting a quick response ; (b) a low probability of cardiac adverse events owing to the low receptor binding affinity ; and (c) an efficacy of the weak α1 agonist similar to that of phenylephrine at the local site of application. Accordingly, we developed a novel topical solution, AB-102, containing a high concentration of a weak α1 agonist. Several studies were conducted to test the safety and efficacy of AB-102. In a dose escalating safety study, utilizing a wearable holter monitor, we observed no cardiac or hemodynamic adverse events. In addition, in a controlled efficacy study, AB-102 reduced the number of hairs shed during brushing by up to 77% (average of 38%).

arrector pili ; hair shedding ; piloerection.

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

31 (1)

2018.

121-122

objavljeno

1396-0296

1529-8019

10.1111/dth.12575

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost